Crescent Biopharma, Inc. (CBIO) Net income 2016–2025
Crescent Biopharma, Inc. (CBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$153.9MFY2025 · since FY2016: -$31.8M → -$153.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.9M | -306.4% |
| FY2024 | -$37.9M | -2.7% |
| FY2023 | -$36.9M | +21.0% |
| FY2022 | -$46.7M | +26.4% |
| FY2021 | -$63.4M | -24.3% |
| FY2020 | -$51.0M | +11.9% |
| FY2019 | -$57.9M | -19.9% |
| FY2018 | -$48.3M | -45.0% |
| FY2017 | -$33.3M | -4.6% |
| FY2016 | -$31.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice